Dianthus Therapeutics | MGTA - Srodki Pieniężne I Ekwiwalent

Cena Akcji
87.79
Dzienna Zmiana
4.29 5.14%
Miesięcznie
4.61%
Rocznie
304.56%
Q2 Prognozy TE
85.52




Srodki Pieniężne I Ekwiwalent Zmiana Data
Akebia Therapeutics USD 184.84M 18.4M 2025-12
Alaunos Therapeutics USD 1.38M 553K 2025-12
Avita Medical AUD 10.24M 1.98M 2025-12
Celltrion KRW 29.65B 799.42B 2025-06
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 51.09M 4.9M 2025-12
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
IQVIA Holdings USD 1.98B 166M 2025-12
Kangmei Pharma CNY 1.18B 278M 2025-09
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 2.6B 1.46B 2025-12
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organigram Holdings CAD 7.58M 20.62M 2025-12
Organon & Co USD 574M 98M 2025-12
Pharma Mar EUR 17.82M 3.78M 2025-12
Qiagen NV USD 839M 516.58M 2025-12
Revvity USD 919.86M 11.53M 2025-12
Sartorius EUR 573.8M 32.4M 2026-03
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tectonic Therapeutic USD 253.8M 14.64M 2025-12
Tilray USD 264.83M 43.16M 2025-06
Viatris USD 1.32B 347.1M 2025-12
Xeris Pharmaceuticals USD 111.04M 19.44M 2025-12
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.77B 376.03M 2025-06